Search
Element Search
Structure Search
Thermo Scientific Chemicals
4-(Bromoacetyl)pyridine hydrobromide, 98%
CAS: 5349-17-7 | C7H7Br2NO | 280.947 g/mol
Change view
Chemical Identifiers
CAS5349-17-7
IUPAC Namehydrogen 2-bromo-1-(pyridin-4-yl)ethan-1-one bromide
Molecular FormulaC7H7Br2NO
InChI KeyRGALBQILADNMKA-UHFFFAOYSA-N
SMILES[H+].[Br-].BrCC(=O)C1=CC=NC=C1
View more
Specifications
Specification Sheet
Specification SheetFormPowder
Appearance (Color)White to cream to pale yellow
Assay (Titration ex Bromide)≥97.5 to ≤102.5%
Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase 4-(Bromoacetyl)pyridine hydrobromide was used to prepare 2-Phenyl-4-(4-pyridyl)imidazole.
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
Applications
Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase 4-(Bromoacetyl)pyridine hydrobromide was used to prepare 2-Phenyl-4-(4-pyridyl)imidazole.
Solubility
Soluble in water.
Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Store away from strong oxidizing agents, bases.
Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase 4-(Bromoacetyl)pyridine hydrobromide was used to prepare 2-Phenyl-4-(4-pyridyl)imidazole.
Solubility
Soluble in water.
Notes
Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Store away from strong oxidizing agents, bases.
RUO – Research Use Only
Nigel J. Liverton,; John W. Butcher,; Christopher F. Claiborne,; David A. Claremon,; Brian E. Libby,; Kevin T. Nguyen,; Steven M. Pitzenberger,; Harold G. Selnick,; Garry R. Smith,; Andrew Tebben. Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase . J. Med. Chem. 1999, 42 (12),2180-2190.